… utilization, the self-reported frequency of illicit drug use in … taking antiretroviral therapy at
the time of interview. Compared with non-drug users, the risk of not taking antiretroviral therapy …

… Evidence on the relationship between continuing drug use, drug treatment and progression
of HIV … As mentioned above however, continuing drug use tends to be associated with poorer …

… HIV care for persons who must be referred to HIV care at another site at which adherence to
antiretroviral treatment … describe adherence to antiretroviral treatment for HIV-infected IDUs …

… access to antiretroviral treatment. The French context allowed us to check the impact of
continued drug use on access to antiretroviral treatment when financial barriers to HIV care in …

… active drug injectors in our study likely comprised drug users … antiretroviral therapy relative
to the larger pool of eligible HIV-… injection drug users who are not receiving any treatment ( 30 …

… Using data from ongoing prospective cohorts of HIV-positive illicit drug users linked to
comprehensive pharmacy dispensation records in Vancouver, Canada, we examined factors …

… need to continuously screen and treat patients for drug use as a part of ongoing HIV care. …
illicit substance use (hereafter, “drug use”) on adherence to highly active antiretroviral therapy (…

… antiretroviral therapy’) study, which randomized patients either to continuous therapy or a
drug-… were associated with many side-effects and overlapping toxicities with drugs used to treat …

… of antiretroviral therapy, barriers to successful antiretroviral treatment, developments to limit
treatment … The evolution of antiretroviral therapy is an ongoing process aimed at discovering …

… activity over time (7, 30, 41), which is likely to underestimate the impact of ongoing drug use
on HIV-1 treatment outcomes and disease progression. In our study, we found that persistent …